• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导管消融治疗心房颤动患者时间断与不间断抗凝治疗的比较:一项荟萃分析

Comparison of Interrupted and Uninterrupted Anticoagulation Therapy for Patients With Atrial Fibrillation Undergoing Catheter Ablation: A Meta-Analysis.

作者信息

Jamil Sidra, Batool Saima, Ehsan Ullah Saad, Aschalew Yared N, Zahra Tafseer, Maheshwari Leladher, Anirudh Chunchu Venkata, Amin Adil

机构信息

Accident and Emergency, Glan Clwyd Hospital, Rhyl, GBR.

Internal Medicine, Hameed Latif Hospital, Lahore, PAK.

出版信息

Cureus. 2022 Oct 27;14(10):e30742. doi: 10.7759/cureus.30742. eCollection 2022 Oct.

DOI:10.7759/cureus.30742
PMID:36447720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9700065/
Abstract

Adequate periprocedural anticoagulation is important to prevent complications like transient ischemic attack, stroke, severe esophageal injury, and pulmonary vein stenosis. The aim of this meta-analysis was to compare uninterrupted anticoagulation therapy with interrupted anticoagulation therapy for patients with arrhythmias undergoing catheter ablation. The current meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Several online databases were searched, such as PubMed, Cochrane Library, and Embase, to search for relevant randomized controlled trials (RCTs). The primary outcome included thromboembolic events. Secondary outcomes included major bleeding events and minor bleeding events. A total of eight RCTs were included in the current meta-analysis, encompassing a total of 3893 patients. No significant differences were reported in relation to thromboembolic events (RR: 2.39, 95% CI: 0.41-13.97, p-value: 0.33), major bleeding events (RR: 0.99, 95% CI: 0.50-1.96, p-value: 0.98) and minor bleeding events (RR: 1.55, 95% CI: 0.56-4.30, p-value: 0.40) between the two study groups. This meta-analysis did not find any conclusive evidence for the absence of any difference between the two strategies.

摘要

围手术期进行充分的抗凝治疗对于预防诸如短暂性脑缺血发作、中风、严重食管损伤和肺静脉狭窄等并发症至关重要。本荟萃分析的目的是比较持续性抗凝治疗与间歇性抗凝治疗对接受导管消融术的心律失常患者的疗效。本荟萃分析遵循系统评价和荟萃分析的首选报告项目(PRISMA)指南。检索了多个在线数据库,如PubMed、Cochrane图书馆和Embase,以查找相关的随机对照试验(RCT)。主要结局包括血栓栓塞事件。次要结局包括大出血事件和小出血事件。本荟萃分析共纳入了8项RCT,总计3893例患者。在血栓栓塞事件(风险比:2.39,95%置信区间:0.41 - 13.97,p值:0.33)、大出血事件(风险比:0.99,95%置信区间:0.50 - 1.96,p值:0.98)和小出血事件(风险比:1.55,95%置信区间:0.56 - 4.30,p值:0.40)方面,两个研究组之间未报告有显著差异。本荟萃分析未找到确凿证据表明这两种策略之间不存在差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a95b/9700065/4d9351b43759/cureus-0014-00000030742-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a95b/9700065/aed5437fe747/cureus-0014-00000030742-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a95b/9700065/c385144bf66d/cureus-0014-00000030742-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a95b/9700065/80ddd273bf97/cureus-0014-00000030742-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a95b/9700065/eca5c5ee6f2d/cureus-0014-00000030742-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a95b/9700065/4d9351b43759/cureus-0014-00000030742-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a95b/9700065/aed5437fe747/cureus-0014-00000030742-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a95b/9700065/c385144bf66d/cureus-0014-00000030742-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a95b/9700065/80ddd273bf97/cureus-0014-00000030742-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a95b/9700065/eca5c5ee6f2d/cureus-0014-00000030742-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a95b/9700065/4d9351b43759/cureus-0014-00000030742-i05.jpg

相似文献

1
Comparison of Interrupted and Uninterrupted Anticoagulation Therapy for Patients With Atrial Fibrillation Undergoing Catheter Ablation: A Meta-Analysis.导管消融治疗心房颤动患者时间断与不间断抗凝治疗的比较:一项荟萃分析
Cureus. 2022 Oct 27;14(10):e30742. doi: 10.7759/cureus.30742. eCollection 2022 Oct.
2
Uninterrupted or Minimally Interrupted Direct Oral Anticoagulant Therapy is a Safe Alternative to Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation: An Updated Meta-Analysis.不间断或极少中断的直接口服抗凝治疗是房颤导管消融患者中维生素K拮抗剂的安全替代方案:一项更新的荟萃分析
J Clin Med. 2020 Sep 24;9(10):3073. doi: 10.3390/jcm9103073.
3
Uninterrupted versus interrupted direct oral anticoagulation for catheter ablation of atrial fibrillation: A systematic review and meta-analysis.不停用与间断用直接口服抗凝药行导管消融治疗心房颤动的效果比较:一项系统评价和荟萃分析。
J Cardiovasc Electrophysiol. 2021 Jul;32(7):1995-2004. doi: 10.1111/jce.15043. Epub 2021 Apr 24.
4
Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta-analysis.非维生素 K 拮抗剂口服抗凝剂在心房颤动导管消融中的安全性和有效性:系统评价和荟萃分析。
Cardiovasc Ther. 2018 Oct;36(5):e12457. doi: 10.1111/1755-5922.12457. Epub 2018 Jul 30.
5
Uninterrupted anticoagulation during catheter ablation for atrial fibrillation: no difference in major bleeding and stroke between direct oral anticoagulants and vitamin K antagonists in an updated meta-analysis of randomised controlled trials.在心房颤动导管消融期间不间断抗凝:更新的随机对照试验荟萃分析显示,直接口服抗凝剂与维生素 K 拮抗剂在大出血和卒中方面无差异。
Acta Cardiol. 2021 May;76(3):288-295. doi: 10.1080/00015385.2020.1724689. Epub 2020 Feb 14.
6
Meta-analysis of the safety and efficacy of using minimally interrupted novel oral anticoagulants in patients undergoing catheter ablation for atrial fibrillation.对接受房颤导管消融术的患者使用最小中断新型口服抗凝剂的安全性和有效性的荟萃分析。
J Interv Card Electrophysiol. 2021 Apr;60(3):407-417. doi: 10.1007/s10840-020-00754-6. Epub 2020 May 2.
7
Safety And Efficacy Of Uninterrupted Periprocedural Apixaban In Patients Undergoing Atrial Fibrillation Catheter Ablation: A Metaanalysis Of 1,057 Patients.心房颤动导管消融患者围手术期不间断使用阿哌沙班的安全性和有效性:1057例患者的荟萃分析
J Atr Fibrillation. 2016 Apr 30;8(6):1368. doi: 10.4022/jafib.1368. eCollection 2016 Apr-May.
8
Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation.新型口服抗凝剂与不间断维生素K拮抗剂在房颤导管消融患者中疗效和安全性的Meta分析
Am J Cardiol. 2016 Mar 15;117(6):926-34. doi: 10.1016/j.amjcard.2015.12.027. Epub 2015 Dec 30.
9
New oral anticoagulants compared to warfarin for perioperative anticoagulation in patients undergoing atrial fibrillation catheter ablation: a meta-analysis of continuous or interrupted new oral anticoagulants during ablation compared to interrupted or continuous warfarin.新型口服抗凝药与华法林用于心房颤动导管消融术患者围手术期抗凝的比较:消融期间持续或中断使用新型口服抗凝药与中断或持续使用华法林的荟萃分析
J Interv Card Electrophysiol. 2017 Apr;48(3):267-282. doi: 10.1007/s10840-016-0221-7. Epub 2017 Jan 12.
10
Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events.不停用 vs. 中断围手术期直接口服抗凝剂用于心房颤动导管消融:一项关于消融后血栓栓塞和出血事件的前瞻性随机单中心研究。
Europace. 2019 Feb 1;21(2):259-267. doi: 10.1093/europace/euy148.

引用本文的文献

1
Comparison of short-term efficacy of two bipolar radiofrequency ablation forceps for rheumatic heart disease concomitant with atrial fibrillation.两种双极射频消融钳治疗风湿性心脏病合并心房颤动的短期疗效比较
Front Cardiovasc Med. 2024 Apr 22;11:1335407. doi: 10.3389/fcvm.2024.1335407. eCollection 2024.

本文引用的文献

1
Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias.心律失常成人患者行导管消融术时,中断与不中断抗凝治疗的比较。
Cochrane Database Syst Rev. 2021 Oct 21;10(10):CD013504. doi: 10.1002/14651858.CD013504.pub2.
2
Uninterrupted or Minimally Interrupted Direct Oral Anticoagulant Therapy is a Safe Alternative to Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation: An Updated Meta-Analysis.不间断或极少中断的直接口服抗凝治疗是房颤导管消融患者中维生素K拮抗剂的安全替代方案:一项更新的荟萃分析
J Clin Med. 2020 Sep 24;9(10):3073. doi: 10.3390/jcm9103073.
3
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.
2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
4
Meta-analysis of the safety and efficacy of using minimally interrupted novel oral anticoagulants in patients undergoing catheter ablation for atrial fibrillation.对接受房颤导管消融术的患者使用最小中断新型口服抗凝剂的安全性和有效性的荟萃分析。
J Interv Card Electrophysiol. 2021 Apr;60(3):407-417. doi: 10.1007/s10840-020-00754-6. Epub 2020 May 2.
5
Uninterrupted Direct Oral Anticoagulants in Atrial Fibrillation Catheter Ablation: Ready for Prime Time.心房颤动导管消融术中不间断使用直接口服抗凝剂:已准备好迎接黄金时代。
Arq Bras Cardiol. 2020 May-Jun;114(3):443-445. doi: 10.36660/abc.20200110.
6
Safety and Efficacy of Minimally Interrupted Dabigatran vs Uninterrupted Warfarin Therapy in Adults Undergoing Atrial Fibrillation Catheter Ablation: A Randomized Clinical Trial.接受心房颤动导管消融术的成年人中最小中断达比加群与持续华法林治疗的安全性和疗效:一项随机临床试验。
JAMA Netw Open. 2019 Apr 5;2(4):e191994. doi: 10.1001/jamanetworkopen.2019.1994.
7
Differences in prothrombotic response between the uninterrupted and interrupted apixaban therapies in patients undergoing cryoballoon ablation for paroxysmal atrial fibrillation: a randomized controlled study.阵发性心房颤动患者接受冷冻球囊消融术时阿哌沙班不间断治疗与间断治疗的血栓前状态反应差异:一项随机对照研究。
Heart Vessels. 2019 Sep;34(9):1533-1541. doi: 10.1007/s00380-019-01370-9. Epub 2019 Mar 6.
8
When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation? A multicentre prospective randomized study.非维生素 K 拮抗剂口服抗凝剂在房颤导管消融前何时停药合适?一项多中心前瞻性随机研究。
Eur Heart J. 2019 May 14;40(19):1531-1537. doi: 10.1093/eurheartj/ehy870.
9
Impact of periprocedural anticoagulation therapy on the incidence of silent stroke after atrial fibrillation ablation in patients receiving direct oral anticoagulants: uninterrupted vs. interrupted by one dose strategy.直接口服抗凝剂治疗的房颤患者行消融术后,抗凝治疗对无症状性卒中发生率的影响:不停用 vs. 单次停药策略。
Europace. 2019 Apr 1;21(4):590-597. doi: 10.1093/europace/euy224.
10
Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events.不停用 vs. 中断围手术期直接口服抗凝剂用于心房颤动导管消融:一项关于消融后血栓栓塞和出血事件的前瞻性随机单中心研究。
Europace. 2019 Feb 1;21(2):259-267. doi: 10.1093/europace/euy148.